A detailed history of Founders Financial Alliance, LLC transactions in Novartis Ag stock. As of the latest transaction made, Founders Financial Alliance, LLC holds 2,576 shares of NVS stock, worth $265,508. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,576
Previous 2,576 -0.0%
Holding current value
$265,508
Previous $274,000 8.03%
% of portfolio
0.08%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 23, 2024

BUY
$92.57 - $107.37 $277 - $322
3 Added 0.12%
2,576 $274,000
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $245,129 - $279,093
2,573 New
2,573 $248,000
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $285,201 - $332,062
3,542 New
3,542 $299,000
Q4 2020

Feb 04, 2021

SELL
$78.07 - $94.43 $100,710 - $121,814
-1,290 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $105,960 - $117,390
1,290 New
1,290 $112,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Founders Financial Alliance, LLC Portfolio

Follow Founders Financial Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Alliance, LLC with notifications on news.